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The adultmammalian central nervous system exhibits restricted regenerative potential. Chen et al. (2011) and
El Bejjani and Hammarlund (2012) used Caenorhabditis elegans to uncover intrinsic factors that inhibit
regeneration of axotomized mature neurons, opening avenues for potential therapeutics.In the mature mammalian central nervous
system (CNS), many axons fail to regen-
erate upon injury, resulting in lasting
functional deficits. The inability of mature
mammalian CNS neurons to regenerate
contrasts the robust regenerative poten-
tial of the fish and amphibian nervous
systems, mammalian PNS neurons, and
even juvenile mammalian CNS neurons.
Aguayo and his colleagues demonstrated
that injured adult rat CNS neurons could
reinitiate axon growth in PNS grafts, pro-
viding the first definitive evidence that an
inhibitory environment contributes to the
inability of mature CNS neurons to regrow
(Richardson et al., 1980). Several extrinsic
factors that potently inhibit axon regen-
eration in cultured neurons, including
chondroitin sulfate proteoglycans and
the myelin-based inhibitors MAG, Nogo,
and OMgp, have since been identified (re-
viewed in Zheng et al., 2006). However,
removing Nogo receptor (NgR) was in-
sufficient to induce regeneration of sev-
ered mouse corticospinal axons in vivo
(reviewed in Zheng et al., 2006). These
studies suggest that: (1) removing NgR
fails to remove all environmental inhibi-
tory signaling, as suggested by the neces-
sity of removal of both NgR and PirB,
another myelin inhibitor receptor, for a
near-complete suppression of myelin-
mediated inhibition of cultured neuron re-
generation (Atwal et al., 2008); (2) mature
CNS neurons may also require promoting
factors to initiate regeneration; and/or (3)
CNS neurons have intrinsically limited
regenerative potential upon maturation.
The identification of both extrinsic stimu-
lators and intrinsic inhibitors of axon re-
growth upon injury would thus providepotential new targets to promote nervous
system regeneration.
C. elegans is a rapidly emerging genetic
model for probing axon regeneration in
a mature nervous system. Its simple ner-
vous system and transparency aids fluo-
rescent labeling and precise severing of
single axons by femtosecond (Yanik
et al., 2004) or dye laser (Wu et al., 2007;
Hammarlund et al., 2009) in live animals.
Regenerative growth has been observed
in many C. elegans neurons but has
been most carefully described in the
D-type GABAergic motor neurons and
the PLM mechanosensory neurons. Typi-
cally, severed axons undergo repro-
ducible morphological changes over the
course of several hours, starting with a
retraction of the axon at the site of injury,
followed by the development of a growth
cone-like structure (Yanik et al., 2004).
The filopodia at the leading edge of these
structures extend and guide axons
toward their targets over the course of
several days (Wu et al., 2007). Remark-
ably, the regrowth of GABAergic motor
axons can lead to a partial functional
recovery of the motor circuit (Yanik
et al., 2004; El Bejjani and Hammarlund,
2012).
Comparison of the recovery of severed
axons in various C. elegans mutant back-
grounds has allowed for the identification
of factors that either promote or inhibit
axon regeneration. For example, Dual
Leucine-Zipper Kinase (DLK-1)-mediated
MAPK signaling promotes axon regenera-
tion in multiple C. elegans neurons (Ham-
marlund et al., 2009; Yan et al., 2009). DLK
signaling also promotes Wallerian degen-
eration, as well as the regeneration ofNeuron 73axotomized Drosophila olfactory receptor
neurons and mouse dorsal root ganglion
neurons (Miller et al., 2009; Xiong et al.,
2010). Moreover, similar to vertebrate
neurons, increased calcium and cyclic
AMP facilitate axon regeneration in sev-
ered C. elegans neurons (Ghosh-Roy
etal., 2010).Therefore, conservedmachin-
eries involved in injury repair can be
discovered through the analysis of the
C. elegans nervous system.
Two recent studies published inNeuron
further exploit the robustness of postaxot-
omy regeneration of C. elegans neurons
to identify novel factors that affect the
regenerative capacity of amature nervous
system. Chen et al. (2011) presented the
first systematic examination of genetic
factors that regulate the regenerative
growth of the PLM mechanosensory neu-
ron. The regrowth of its longitudinal axon
upon laser severing during the last larval
stage was monitored in 654 loss- or
gain-of-function mutants. A large number
of genes, with roles in diverse cellular
processes—signaling, cytoskeleton re-
modeling, adhesion, neurotransmission,
and gene expression—are required for
robust PLM axon regrowth in adults.
By contrast, only 16 genes emerged as
potent inhibitors of axon regrowth; the
loss of these genes resulted in significant
overgrowth of the PLM axon upon axot-
omy. Among them, the Exchange Factor
for Arf6 EFA-6, a conserved Guanine
Exchange Factor (GEF), functions in the
PLM neuron to both prevent axon overex-
tension during development and potently
inhibit axon regeneration postaxotomy in
late-stage larvae. Severed PLM axons
exhibit proportionally more regrowth, January 26, 2012 ª2012 Elsevier Inc. 207
Figure 1. Cell-Autonomous Signaling Pathways that Inhibit the Regeneration of Axotomized
C. elegans Neurons
Notch signaling, mediated by Notch receptor/LIN-12 and its processing enzymes ADAM10/SUP-17 and
g-secretases SEL-12 and HOP-1, inhibits growth cone initiation, an early stage of axon regeneration. The
Notch Intracelluar Domain (NICD) translocates to the nucleus, implying a role in transcriptional regulation
of unidentified targets. An Arf Guanine nucleotide Exchange Factor, EFA-6, inhibits axon regrowth by
destabilizing microtubules at the site of injury. efa-6(lf), but not the loss of Notch signaling components,
partially bypasses the requirement of the DLK-1 MAPK signaling and CEBP-1-mediated local translation
for axon regeneration.
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the absence of EFA-6. EFA-6 activity
also most potently limits regrowth during
the early phase of regeneration. These
results suggest that EFA-6 likely in-
hibits axongrowth reinitiation. Intriguingly,
EFA-6 exerts its inhibitory effect on injury-
induced regrowth not primarily through its
GEF domain, but instead via a conserved
but functionally poorly defined N-terminal
region. Previous work showed that in
addition to its role as aGEF, theN terminus
of EFA-6 decreasesmicrotubule growth at
the cell cortex in C. elegans embryos
(O’Rourke et al., 2010). Further supporting
the involvement of microtubule remodel-
ing in EFA-6-mediated inhibition on axon
regeneration, the application of Taxol, a
microtubule-stabilizing compound, par-
tially restored the decreased regrowth of
PLM axon induced by an overexpression
of the N-terminal region of EFA-6. Taken
together, these results suggest that
EFA-6 prevents the initiation of axon
regrowth by counteracting microtubule
polymerization.
In this issue of Neuron, El Bejjani and
Hammarlund report the identification of208 Neuron 73, January 26, 2012 ª2012 Elsea new set of inhibitors of axon regenera-
tion in mature motor neurons (El Bejjani
and Hammarlund, 2012). Upon severing
the commissural axons of GABAergic
motor neurons, a fraction of them effec-
tively regrow and partially restore motor
deficits associated with injury, implying
a partial restoration of synaptic connec-
tivity (Yanik et al., 2004; El Bejjani and
Hammarlund, 2012). These authors found
that a canonical Notch signaling cascade,
regulators of C. elegans vulva morpho-
genesis, also functions as potent intrinsic
inhibitors of commissural axon regrowth
and functional restoration of motor circuit
activity (El Bejjani and Hammarlund,
2012). The loss of one of the C. elegans
Notch receptors LIN-12 in GABAergic
neurons results in accelerated growth
cone initiation and regrowth of the axon.
Conversely, increased LIN-12 signaling
leads to reduced regeneration. Unlike
the case for EFA-6 (Chen et al., 2011),
Notch/LIN-12 specifically limits regenera-
tion after axotomy, without affecting axon
growth during development. The ADAM
metalloproteases SUP-17 and ADM-4,
and the g-secretases/Presenilins SEL-12vier Inc.and HOP-1, cleave Notch/LIN-12 and
release the Notch intracellular domain
(NICD). Upon its translocation into the
nucleus, the NICD regulates development
through modulating transcription. These
authors showed that the processing of
Notch/LIN-12 by SUP-17, SEL-12, and
HOP-1 immediately postaxotomy is nec-
essary for effective inhibition of axon
regeneration; they were also successful
in potentiating axon regeneration by in-
jecting a g-secretase inhibitor N-[N-(3,5-
difluorophenacetyl)-L-alanyl]S-phenylgly-
cine t-butyl ester (DAPT) immediately
after axotomy. These results indicate that
Notch signaling inhibits the initiation of
axon regeneration. Interestingly, the appli-
cation of DAPT two hours after axotomy
failed to affect regeneration, suggesting
that the inhibitory Notch activity is fairly
rapidly triggered upon injury.
A key issue to be addressed in future
studies is how multiple intrinsic signaling
events are activated upon injury and
interact with each other to determine
the injury response (Figure 1). Both inhibi-
tory factors for regeneration, EFA-6 and
Notch/LIN-12, are most effective during
a narrow time window immediately fol-
lowing axotomy. Similarly, regeneration-
promoting DLK-1 signaling is most criti-
cally requiredwithin two hours of the injury
to enable growth cone initiation (Hammar-
lund et al., 2009). Upstream regulators of
EFA-6 remain elusive, but signals stem-
ming from the site of injury, such as
calcium influx and an increase of cAMP,
probably play a role in DLK-1 activation
(Ghosh-Roy et al., 2010). In the case of
Notch signaling, no single known Notch
ligand was found necessary to inhibit
axon regeneration (El Bejjani and Ham-
marlund, 2012). One ligand DSL/LAG-2
even mildly promotes regrowth (El Bejjani
and Hammarlund, 2012). It is possible
that multiple ligands function redundantly
upon injury to activate Notch (Figure 1).
These observations, however, also sup-
port a tantalizing possibility that axotomy
itself is a shared trigger for multiple sig-
naling responses, including the activation
of Notch processing independently of its
canonical ligands.
Despite a similar temporal requirement,
DLK-1, EFA-6, and Notch signaling do not
exhibit unequivocal linear genetic inter-
actions. In efa-6; dlk-1 double mutants,
severed PLM axons extend significantly
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failed to form growth cone-like structures
(Chen et al., 2011). The loss of Notch
signaling could not bypass the require-
ment of DLK-1 to reinitiate growth cones
in GABAergic neurons (El Bejjani and
Hammarlund, 2012), arguing against
a simplistic view where DLK-1 initiates
axon regeneration by suppressing inhibi-
tory signals from EFA-6 or Notch. While
the genetic interactions between the
Notch signaling and EFA-6 remain to be
determined, an interplay of multiple,
parallel signaling events may determine
the injury response in individual neurons.
These studies reinforce a notion that
both common and specific factors con-
tribute to the regeneration of different
neurons. DLK-1 activity is necessary for
the regrowth of both GABAergic motor
neurons and PLM mechanosensory neu-
rons. Whether EFA-6, an inhibitor of PLM
axon regeneration, also affects the re-
generation in GABAergic motor neurons
remains to be tested. Whether Notch sig-
naling significantly affects PLM regrowth
requires more thorough investigation
(Chen et al., 2011). However, as observed
for Notch signaling components (El Bej-
jani and Hammarlund, 2012), some fac-
tors that regulate regeneration are prob-
ably cell type specific or are expressed
at different levels in neuronal subtypes.
Comparing such differences may yield
insights into the determinants of the
regenerative potential of specific neuronal
classes.
Another common theme emerging from
these and other studies is that axon
regeneration involves transcriptional and
posttranscriptional regulation. The main
Notch effector NICD localizes to the
nucleus of injured GABAergic neurons,
and the constitutive expression of NICD
potently inhibits their commissural axon
regeneration (El Bejjani and Hammarlund,
2012). In PLM neurons, DLK-1-mediatedregrowth requires a bZip transcription
factor CEBP-1 and its local translation
at the severed site (Yan et al., 2009).
In Drosophila neurons, DLK-mediated
regeneration involves the Fos transcrip-
tion factor (Xiong et al., 2010). Additional
transcription factors, as well as regulators
of chromatin remodeling and mRNA
metabolism, influence PLM axon regener-
ation (Chen et al., 2011). These observa-
tions indicate that local and nuclear gene
regulatory responses may contribute to
different phases of regeneration. It will
be important to identify and compare the
downstream target(s) of these regulatory
proteins.
As demonstrated in these two recent
studies, the repertoire of C. elegans ge-
netic mutants allows for both genome-
wide screens and targeted investigation
of factors that positively and negatively
regulate axon regeneration. The factors
and genetic pathways identified by these
studies, however, probably represent
only the tip of the iceberg. Recently iden-
tified intrinsic inhibitors for adult mouse
retinal ganglion cell axon regeneration
include more transcriptional regulators,
such as the Kru¨ppel-like factors, repres-
sors of mTOR-mediated protein transla-
tion PTEN and TSC1, as well as SOCS3,
a negative regulator of JAK/STAT sig-
naling (reviewed in Liu et al., 2011). The
dual deletion of PTEN and SOCS3 results
in significantly more sustained axon re-
generation than either single gene dele-
tion (Sun et al., 2011), further supporting
the view that the interplay of multiple
regeneration-promoting factors deter-
mines the regenerative ability of neurons.
Given that the cellular response to injuries
inflicted by various forms of axotomy and
neurological trauma may differ, assessing
the effect of multiple factors in different
neurons, injury paradigms, and animal
models is critical for revealing general
and specific targets for nervous systemNeuron 73repair. Results from Chen et al. (2011)
and El Bejjani and Hammarlund (2012)
provide exciting starting points for
testing the role of orthologous proteins
in other animal and injury models for
axon regeneration.REFERENCES
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